CryoTherapeutics has developed a patented system consisting of a console and an intracoronary balloon catheter to be used by interventional cardiologists. The Cryotherapy System (CTS) is a lesion-specific, implant-free device designed to cool vulnerable plaque at high risk of rupture in order to stabilize it and potentially prevent major cardiac events in patients with non-flow-limiting Coronary Artery Disease.

Using X-ray guidance, the catheter is advanced until the balloon is positioned at the level of the plaque requiring treatment. The operator inflates the balloon and initiates the cryo-procedure: the console then delivers the cooling agent through the catheter in a controlled manner to cool down the solution inside the balloon, maintaining a temperature between -10°C to -20°C required for the treatment of the vulnerable plaque.

Each catheter is for a single use only whereas the console is reusable.



CryoTherapeutics closes new €12.3 million financing round.

Find out more